Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E S Schultz

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The British Journal of Dermatology|October 1, 1995
Systemic corticosteroids are important in the treatment of Fournier's gangrene: a case reportE S Schultz, T L Diepgen, P von den Driesch, et al.
Tissue Antigens|March 22, 2001
A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytesE S Schultz, Y Zhang, R Knowles, et al.
Allergy|February 24, 2015
Asthma phenotypes and lung function up to 16 years of age-the BAMSE cohortJ Hallberg, P Thunqvist, E S Schultz, et al.
European Journal of Immunology|July 4, 2001
A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cellsP Chaux, B Lethé, J Van Snick, et al.
Tissue Antigens|October 9, 2002
A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18J Bilsborough, C Panichelli, M-T Duffour, et al.
Cancer Research|December 5, 2000
A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytesE S Schultz, B Lethé, C L Cambiaso, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The British Journal of Dermatology|October 1, 1995
Systemic corticosteroids are important in the treatment of Fournier's gangrene: a case reportE S Schultz, T L Diepgen, P von den Driesch, et al.
Tissue Antigens|March 22, 2001
A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytesE S Schultz, Y Zhang, R Knowles, et al.
Allergy|February 24, 2015
Asthma phenotypes and lung function up to 16 years of age-the BAMSE cohortJ Hallberg, P Thunqvist, E S Schultz, et al.
European Journal of Immunology|July 4, 2001
A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cellsP Chaux, B Lethé, J Van Snick, et al.
Tissue Antigens|October 9, 2002
A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18J Bilsborough, C Panichelli, M-T Duffour, et al.
Cancer Research|December 5, 2000
A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytesE S Schultz, B Lethé, C L Cambiaso, et al.
Pageof 2